Ebola Vaccine May Need Months of Work Before Human Trials (1)

May 19, 2026, 6:54 PM UTC

Doctors battling a rare strain of Ebola in central Africa will probably need to wait many months for a vaccine to be ready for human trials, the Coalition for Epidemic Preparedness Innovations said, underscoring the challenges health authorities face in combating the outbreak.

CEPI and its partners will start the vaccine development process immediately for multiple candidates, Chief Executive Officer Richard Hatchett said in an interview Tuesday. However, lab testing and evidence from animal trials will be needed before human studies can begin, he said. Some potential candidates have undergone initial animal testing.

“These are very, very early-stage vaccines,” Hatchett ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.